Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.50 |
| ▸ | CYP2A6 | P11509 | 3/20 | 0.43 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.43 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | CD44 | P16070 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.36 |
| ▸ | ACHE | P22303 | 1/20 | 0.36 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA9 | Q16790 | 1/20 | 0.36 |
| ▸ | HTR7 | P34969 | 2/20 | 0.36 |
| ▸ | NOS3 | P29474 | 2/20 | 0.36 |
| ▸ | NOS2 | P35228 | 2/20 | 0.36 |
| ▸ | SRC | P12931 | 1/20 | 0.35 |
| ▸ | NOS1 | P29475 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12200494 | 0.81 | CYP2A6 (0.50) | L3MBTL1CYP2A6CYP1A2ALDH1A1TSHR | |
| SCHEMBL2508698 | 0.81 | HSP90AA1 (0.44) | L3MBTL1CYP2A6CYP1A2ALDH1A1SMN1; SMN2 | |
| SCHEMBL13312929 | 0.78 | CYP2A6 (0.36) | CYP2A6CYP1A2ALDH1A1CD44TSHR | |
| SCHEMBL18938791 | 0.76 | CYP2A6 (0.43) | CYP2A6CYP1A2ALDH1A1SMN1; SMN2CD44 | |
| SCHEMBL24689624 | 0.75 | CYP2A6 (0.38) | CYP2A6CYP1A2ALDH1A1CD44TSHR | |
| SCHEMBL13589308 | 0.75 | L3MBTL1 (0.39) | L3MBTL1CYP2A6CYP1A2ALDH1A1SMN1; SMN2 | |
| SCHEMBL13869971 | 0.75 | CYP2A6 (0.43) | L3MBTL1CYP2A6CYP1A2ALDH1A1CD44 | |
| SCHEMBL15855019 | 0.75 | LMNA (0.37) | CYP2A6CYP1A2ALDH1A1CD44HTR7 | |
| SCHEMBL20072679 | 0.75 | C1R (0.34) | CYP2A6CYP1A2ALDH1A1CD44TSHR | |
| SCHEMBL18216913 | 0.73 | L3MBTL1 (0.54) | L3MBTL1CYP1A2ALDH1A1SMN1; SMN2TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230380274-A1 | ORTHO-SUBSTITUTED THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-23 | — | — | US | disclosed |
| US-20230380274-A1 | ORTHO-SUBSTITUTED THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-11-23 | — | — | US | disclosed |
| US-11758808-B2 | Ortho-substituted thermally activated delayed fluorescence material and organic light-emitting device comprising same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-09-12 | — | — | US | disclosed |
| US-11758808-B2 | Ortho-substituted thermally activated delayed fluorescence material and organic light-emitting device comprising same | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-09-12 | — | — | US | disclosed |
| US-20230189641-A1 | ORTHO-SUBSTITUTED THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-06-15 | — | — | US | disclosed |
| US-20230189641-A1 | ORTHO-SUBSTITUTED THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2023-06-15 | — | — | US | disclosed |
| US-20180123049-A1 | ORTHO-SUBSTITUTED THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-05-03 | — | — | US | disclosed |
| US-20180123049-A1 | ORTHO-SUBSTITUTED THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2018-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230189641-A1 | ORTHO-SUBSTITUTED THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | TEAD2, TEAD3, TEAD4 | L3MBTL1 464/4885CYP2A6 1181/4885CYP1A2 1169/4885 |
| US-20230380274-A1 | ORTHO-SUBSTITUTED THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | TEAD2, TEAD3, TEAD4 | L3MBTL1 464/4885CYP2A6 1181/4885CYP1A2 1169/4885 |
| US-20180123049-A1 | ORTHO-SUBSTITUTED THERMALLY ACTIVATED DELAYED FLUORESCENCE MATERIAL AND ORGANIC LIGHT-EMITTING DEVICE COMPRISING SAME | TEAD2, TEAD3, TEAD4 | L3MBTL1 464/4885CYP2A6 1181/4885CYP1A2 1169/4885 |
| US-11758808-B2 | Ortho-substituted thermally activated delayed fluorescence material and organic light-emitting device comprising same | TEAD2, TEAD3, TEAD4 | L3MBTL1 464/4885CYP2A6 1181/4885CYP1A2 1169/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.